SEC Filing Analysis: SANGAMO THERAPEUTICS, INC (SGMO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Principal Financial Officer disposed of shares in a non-discretionary transaction to cover tax obligations related to vested Restricted Stock Units (RSUs).
• Market Impact: Negligible. This type of transaction is common and does not signal a change in insider sentiment.

Company Information

Field	Value
Company	SANGAMO THERAPEUTICS, INC
Ticker Symbol	SGMO
CIK	0001001233
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Duraibabu Prathyusha
CIK	0001779092
Title/Position	PRINCIPAL FINANCIAL OFFICER
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	F - Payment of tax liability by withholding securities
Security Type	Common Stock
Shares Involved	45,225
Price Per Share	$0.66
Total Value	$29,848.50
Shares Owned After	699,262
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$29,848.50
% of Market Cap	0.016%
Shares Transacted	45,225
% of Shares Outstanding	0.015%
Post-Transaction Ownership	699,262 shares (0.23% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $190 million, this $29.8k transaction is immaterial, representing a tiny fraction of its total value.
• Ownership Concentration: The insider's post-transaction ownership of 0.23% is not a controlling stake, and this transaction does not significantly alter their holding percentage.
• Dilution Impact: This transaction is a disposition, not an issuance, so it has no dilutive effect. It is related to the vesting of previously granted equity.
• Transaction Significance: The transaction's value is less than 0.1% of the market cap and the shares involved are less than 0.1% of shares outstanding. Combined with the 'F' transaction code, this confirms the event's low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The market typically does not react to 'F' coded transactions as they are automatic, non-discretionary sales to cover tax liabilities. They do not reflect an insider's decision to reduce their exposure to the company.

Volume & Sentiment

• Expected Volume Impact: None. The shares were withheld by the issuer and not sold on the open market.
• Sentiment Indicator: Neutral. This filing does not provide any bullish or bearish signals regarding the insider's outlook on the company.

Investment Insights

Positive Market Indicators

• N/A. This filing is procedural and does not contain positive market indicators.

Risk Factors

• N/A. This filing does not present any new risk factors.

Key Takeaways

1. Non-Discretionary Sale: This was a mandatory sale to cover taxes on vested RSUs, not a voluntary open-market sale.
2. Low Materiality: The transaction size is insignificant relative to the company's market cap and total shares outstanding.
3. No Change in Sentiment: The filing should not be interpreted as a change in the executive's confidence in the company's future prospects.

Additional Context

Transaction Notes

• Special Circumstances: As per footnote 1, the shares were surrendered for mandatory tax withholding purposes upon the vesting of RSUs. This is a common practice and is not a discretionary trade by the reporting person.